Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 2024-06-15 20:50
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI) 2024-06-14 21:30
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary 2024-06-14 08:34
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement 2024-06-13 20:30
Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy 2024-06-13 18:03
NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore 2024-06-13 10:00
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2024-06-13 08:00
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
2024ASCO｜Memorial Sloan Kettering Cancer Center (MSK)'s Prof. Wungki Park Unveils Precision Targeting of TF in Pancreatic Cancer, Signaling ADC Drug Innovations 2024-06-12 19:31
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions 2024-06-12 08:00
Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference 2024-06-11 18:00
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility 2024-06-11 15:57
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE 2024-06-11 11:25
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024 2024-06-11 08:10
Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting 2024-06-11 08:00
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024 2024-06-10 20:00
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A 2024-06-10 16:18
India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad 2024-06-10 15:40
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study 2024-06-10 13:56
1 28 29 30 31 32 451